West Tower Group LLC Buys 69,714 Shares of Perrigo Company plc $PRGO

West Tower Group LLC grew its stake in Perrigo Company plc (NYSE:PRGO) by 40.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 242,955 shares of the company’s stock after purchasing an additional 69,714 shares during the period. Perrigo makes up approximately 7.6% of West Tower Group LLC’s portfolio, making the stock its 2nd biggest holding. West Tower Group LLC owned about 0.18% of Perrigo worth $3,382,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of PRGO. Vanguard Group Inc. increased its holdings in shares of Perrigo by 7.9% in the fourth quarter. Vanguard Group Inc. now owns 14,983,369 shares of the company’s stock valued at $208,568,000 after purchasing an additional 1,101,154 shares during the period. Ion Asset Management Ltd. increased its holdings in shares of Perrigo by 34.7% in the second quarter. Ion Asset Management Ltd. now owns 3,817,621 shares of the company’s stock valued at $102,007,000 after purchasing an additional 983,727 shares during the period. Goldman Sachs Group Inc. increased its holdings in shares of Perrigo by 126.6% in the first quarter. Goldman Sachs Group Inc. now owns 1,159,768 shares of the company’s stock valued at $32,520,000 after purchasing an additional 647,982 shares during the period. State Street Corp increased its holdings in shares of Perrigo by 9.5% in the second quarter. State Street Corp now owns 7,340,323 shares of the company’s stock valued at $196,134,000 after purchasing an additional 637,678 shares during the period. Finally, Ameriprise Financial Inc. increased its holdings in shares of Perrigo by 52.5% in the second quarter. Ameriprise Financial Inc. now owns 1,308,334 shares of the company’s stock valued at $34,959,000 after purchasing an additional 450,247 shares during the period. Institutional investors and hedge funds own 95.91% of the company’s stock.

Perrigo Stock Up 0.5%

Perrigo stock opened at $11.12 on Wednesday. The company has a debt-to-equity ratio of 1.45, a current ratio of 2.72 and a quick ratio of 1.59. Perrigo Company plc has a 1-year low of $9.23 and a 1-year high of $28.43. The company has a market cap of $1.54 billion, a PE ratio of -0.85, a price-to-earnings-growth ratio of 1.29 and a beta of 0.52. The stock’s 50 day moving average price is $10.83 and its 200 day moving average price is $13.37.

Perrigo (NYSE:PRGO) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.04. Perrigo had a positive return on equity of 9.96% and a negative net margin of 43.50%.The firm had revenue of $841.80 million for the quarter, compared to the consensus estimate of $1.04 billion. During the same period in the previous year, the business earned $0.60 earnings per share. The company’s revenue for the quarter was down 7.2% compared to the same quarter last year. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, sell-side analysts predict that Perrigo Company plc will post 2.14 EPS for the current fiscal year.

Perrigo Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Shareholders of record on Friday, May 29th will be given a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a yield of 10.4%. The ex-dividend date is Friday, May 29th. Perrigo’s payout ratio is presently -8.85%.

Wall Street Analysts Forecast Growth

PRGO has been the topic of a number of recent research reports. Zacks Research raised Perrigo from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Canaccord Genuity Group dropped their target price on Perrigo from $20.00 to $17.00 and set a “buy” rating on the stock in a report on Friday, February 27th. Argus upgraded Perrigo to a “hold” rating in a research note on Wednesday, January 14th. Weiss Ratings downgraded Perrigo from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, April 29th. Finally, Jefferies Financial Group restated a “hold” rating on shares of Perrigo in a research note on Thursday, February 26th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $19.33.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.